Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
Reports
FY2026 first quarter results briefing session script
by Chris Miller
FY2026-Q1 financial report (Apr. 1-Jun. 30, 2026)
by Chris Miller
FY2026 first quarter results briefing session material
by Chris Miller
Partial correction: consolidated financial results for the full year ended March 31, 2026 (FY2025) (Japanese standard)
by JCR Pharmaceuticals
Partial correction: consolidated financial results for the full year ended March 31, 2025 (FY2024) (Japanese standard)
by JCR Pharmaceuticals
FY2025 results briefing session script
by JCR Pharmaceuticals
FY2025 results briefing session movie
by JCR Pharmaceuticals
FY2025 results briefing session material
by JCR Pharmaceuticals
Consolidated financial results for the year ended March 31, 2026 (FY2025)
by JCR Pharmaceuticals
Notice concerning partial corrections to the annual securities report
by JCR Pharmaceuticals
1
2
3
…
5
Privacy Preference Center
Privacy Preferences
